Nucleus Biologics specializes in providing advanced solutions for cell culture media, particularly tailored for cell and gene therapy applications. Their offerings include a range of customizable products such as NB-AIR and NB-Lux, which facilitate the design and configuration of cell culture media. These platforms allow researchers to create formulations that meet specific project requirements, ensuring transparency in component selection and adherence to Good Manufacturing Practices (GMP). The company emphasizes the importance of high-quality media in optimizing cell performance, which is critical for the success of therapeutic products.

In addition to media design, Nucleus Biologics offers a variety of pre-optimized supplements and reagents, including xeno-free options, to enhance cell function. Their Krakatoa™ Media Maker provides a pod-based solution for on-demand media preparation, streamlining the transition from laboratory-scale to bioreactor applications. The company also focuses on sustainability by reducing waste and greenhouse gas emissions in their manufacturing processes. Overall, Nucleus Biologics aims to empower scientists with the tools necessary for efficient and effective cell culture, ultimately accelerating the path to commercialization for innovative therapies.

United States

Nucleus Biologics is a San Diego based biotechnology company and a global provider of media and supplements for the cell and gene therapy space.  Their mission is to speed the time from scientific discovery to cure by driving reproducibility through Precision Cell Culture products and tools. Nucleus Biologics delivers innovative, transparent and cGMP products and services with the goal of disrupting the market and eliminating antiquated practices and products. Ultimately, Nucleus Biologics strives to create a new paradigm that serves both scientists and clinicians, while reducing the environmental footprint of cell culture.

Nucleus Biologics

Company Details